Inogen (NASDAQ:INGN) Raised to “Moderate Buy” at Needham & Company LLC
Needham & Company LLC upgraded shares of Inogen (NASDAQ:INGN – Free Report) from a hold rating to a moderate buy rating in a report released on Thursday morning, Marketbeat Ratings reports. Needham & Company LLC currently has $12.00 target price on the medical technology company’s stock. Several other equities research analysts have also issued reports […]
Needham & Company LLC upgraded shares of Inogen (NASDAQ:INGN – Free Report) from a hold rating to a moderate buy rating in a report released on Thursday morning, Marketbeat Ratings reports. Needham & Company LLC currently has $12.00 target price on the medical technology company’s stock. Several other equities research analysts have also issued reports […]
